ロード中...
Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1
We tested the hypothesis that ex vivo hepatocyte gene therapy can correct the metabolic disorder in fumarylacetoacetate hydrolase–deficient (Fah(−/−)) pigs, a large animal model of hereditary tyrosinemia type 1 (HT1). Recipient Fah(−/−)pigs underwent partial liver resection and hepatocyte isolation...
保存先:
| 出版年: | Sci Transl Med |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5477771/ https://ncbi.nlm.nih.gov/pubmed/27464750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aaf3838 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|